Clinical Trials
4
Active:1
Completed:3
Trial Phases
1 Phases
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (100.0%)Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease
Phase 2
Active, not recruiting
- Conditions
- Ocular Graft-versus-host Disease
- Interventions
- Drug: PlaceboDrug: Pro-ocular™ Topical Gel 1%
- First Posted Date
- 2021-02-24
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Glia, LLC
- Target Recruit Count
- 44
- Registration Number
- NCT04769648
- Locations
- 🇺🇸
BostonSight, Needham, Massachusetts, United States
Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel
Phase 2
Completed
- Conditions
- Contact Lens DiscomfortContact Lens-induced Corneal DisorderContact Lens Acute Red EyeContact Lens-induced Corneal Fluorescein Staining
- Interventions
- Drug: CLM2 topical gelDrug: Placebo topical gel
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Glia, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT03994406
- Locations
- 🇺🇸
UC Berkeley Clinical Research Center, Berkeley, California, United States
Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.
Phase 2
Completed
- Conditions
- Chronic Ocular Graft-versus-host Disease
- Interventions
- Drug: Pro-ocular™ topical gelDrug: Placebo topical gel
- First Posted Date
- 2019-06-18
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Glia, LLC
- Target Recruit Count
- 33
- Registration Number
- NCT03990051
- Locations
- 🇺🇸
Massachusetts Eye and Ear Longwood, Boston, Massachusetts, United States
Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101
- First Posted Date
- 2016-01-15
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Glia, LLC
- Target Recruit Count
- 49
- Registration Number
- NCT02656394
- Locations
- 🇺🇸
New York Eye & Ear Infirmary of Mount Sinai, New York, New York, United States
News
No news found